Lexaria Bioscience Minority Interest

As of the most recent data (May 2026), LEXX shows a minority interest of $-390K. That compares with $-390K in the prior-year period — down 2.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LEXX's minority interest is now $-390K (was $-390K) — a 2.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Lexaria Bioscience is outperforming or lagging.

Tracking LEXX's minority interest over time shows whether Lexaria Bioscience is scaling, shrinking, or reshaping that part of the business. The current reading is $-390K That compares with $-390K in the prior-year period — down 2.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this minority interest page, Stockcircle has Lexaria Bioscience's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect minority interest (currently $-390K) with ownership activity and broader fundamentals.

Lexaria Bioscience's minority interest is $-390K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.